272 related articles for article (PubMed ID: 16125258)
1. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
[TBL] [Abstract][Full Text] [Related]
2. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
Docherty JJ; Smith JS; Fu MM; Stoner T; Booth T
Antiviral Res; 2004 Jan; 61(1):19-26. PubMed ID: 14670590
[TBL] [Abstract][Full Text] [Related]
3. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
Kokuba H; Aurelian L; Neurath AR
Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
6. An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.
Yin S; Li Y; Xia H; Zhao J; Zhang Z; Tang S; Kou Z; Chen J; Yu J; Fan Z; Li T
J Virol Methods; 2013 May; 189(2):317-20. PubMed ID: 23454799
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
9. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.
Carlucci MJ; Scolaro LA; Noseda MD; Cerezo AS; Damonte EB
Antiviral Res; 2004 Nov; 64(2):137-41. PubMed ID: 15498610
[TBL] [Abstract][Full Text] [Related]
11. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice.
Shestakov A; Jenssen H; Nordström I; Eriksson K
Antiviral Res; 2012 Mar; 93(3):340-5. PubMed ID: 22269645
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
13. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
14. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibition of herpes simplex virus replication.
Docherty JJ; Fu MM; Stiffler BS; Limperos RJ; Pokabla CM; DeLucia AL
Antiviral Res; 1999 Oct; 43(3):145-55. PubMed ID: 10551373
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.
Valencia F; Veselenak RL; Bourne N
Methods Mol Biol; 2013; 1030():315-26. PubMed ID: 23821278
[TBL] [Abstract][Full Text] [Related]
17. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
18. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
19. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
20. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
